Assignee
TRISALUS LIFE SCIENCES INC
US·12 granted patents·15 pending applications·8 citations·filing 2018–2025
Top patents by PatentIndex Score
27 records- 0187US11400263B1System and method for selective pressure-controlled therapeutic deliveryTRISALUS LIFE SCIENCES INC·Filed 2018·Granted Aug 2, 2022·8 cites·21 claims
- 0280US2022267772A1Immunostimulatory sequence oligonucleotides and methods of using the sameTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 0379US12390621B1System and method for selective pressure-controlled therapeutic deliveryTRISALUS LIFE SCIENCES INC·Filed 2022·Granted Aug 19, 2025·0 cites·25 claims
- 0476US11312965B2Immunostimulatory sequence oligonucleotides and methods of using the sameTRISALUS LIFE SCIENCES INC·Filed 2018·Granted Apr 26, 2022·0 cites·13 claims
- 0575US12472052B2Dynamic microvalve protection deviceTRISALUS LIFE SCIENCES INC·Filed 2021·Granted Nov 18, 2025·0 cites·31 claims
- 0674US12226604B2Dual pathway therapeutic agent deliveryTRISALUS LIFE SCIENCES INC·Filed 2022·Granted Feb 18, 2025·0 cites·38 claims
- 0773US12502479B2Closed tip dynamic microvalve protection deviceTRISALUS LIFE SCIENCES INC·Filed 2021·Granted Dec 23, 2025·0 cites·14 claims
- 0871US12377245B2Method of delivering a therapeutic agent to a solid tumor for treatmentTRISALUS LIFE SCIENCES INC·Filed 2021·Granted Aug 5, 2025·0 cites·11 claims
- 0971US12201508B2Dynamic microvalve protection deviceTRISALUS LIFE SCIENCES INC·Filed 2020·Granted Jan 21, 2025·0 cites·17 claims
- 1071US2023025500A1System and method for selective pressure-controlled therapeutic deliveryTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 1168US12138424B2Closed tip dynamic microvalve protection deviceTRISALUS LIFE SCIENCES INC·Filed 2020·Granted Nov 12, 2024·0 cites·21 claims
- 1268US2025186752A1Dual pathway therapeutic agent deliveryTRISALUS LIFE SCIENCES INC·Filed 2025·Application pending·0 cites
- 1368US2024115807A1Systems and Methods for Pressure-Facilitated Therapeutic Agent DeliveryTRISALUS LIFE SCIENCES INC·Filed 2023·Application pending·0 cites
- 1457US11338117B2Implantable dual pathway therapeutic agent delivery portTRISALUS LIFE SCIENCES INC·Filed 2019·Granted May 24, 2022·0 cites·57 claims
- 1557US2024206959A1Systems and methods for selectively inducing vasoconstriction to increase therapeutic uptake in tissueTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 1656US2023193374A1Tissue homogenization buffer for efficient quantitation of a therapeutic oligonucleotide in multiple tissuesTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 1755US12433597B2Atraumatic occlusive system with compartment for measurement of vascular pressure changeTRISALUS LIFE SCIENCES INC·Filed 2019·Granted Oct 7, 2025·0 cites·22 claims
- 1855US2023374523A1Cancer therapy using toll-like receptor agonistsTRISALUS LIFE SCIENCES INC·Filed 2021·Application pending·0 cites
- 1955US2024180952A1Cancer therapy using toll-like receptor agonistsTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2055US2024164788A1Therapeutic treatment device with braided-strand microvalve occluder having modified filter coatingTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2154US2024207571A1Systems and methods for controlling flow of therapeutic agent delivered to an infusion catheterTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2253US2024225654A9Therapeutic treatment device with braided microvalve occluder having collapsible coverTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2352US11850398B2Systems and methods for pressure-facilitated therapeutic agent deliveryTRISALUS LIFE SCIENCES INC·Filed 2019·Granted Dec 26, 2023·0 cites·36 claims
- 2452US2023364125A1Cancer therapy using toll-like receptor agonistsTRISALUS LIFE SCIENCES INC·Filed 2021·Application pending·0 cites
- 2551US2024238558A9Therapeutic treatment device with braided microvalve occluderTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2651US2024218068A1Cancer therapy using checkpoint inhibitorsTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2749US2025101438A1Methods of treating immune dysfunction in liver cancer with toll-like receptor agonistsTRISALUS LIFE SCIENCES INC·Filed 2023·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →